Article
Optimizing CRISPR/Cas9 genome editing in primary human hematopoietic cells to advance studies into HIV biology
2026-08-05
Abstract excerpt
Defining how human host factors shape HIV-1 infection in vivo remains essential for the development of genetically engineered cell therapies. Here, we established a non-viral CRISPR/Cas9 ribonucleoprotein-based platform for efficient single and multiplex gene editing in primary human CD34 + hematopoietic stem and progenitor cells (HSPCs). Edited HSPCs retained viability, proliferative capacity, primitive immunop...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1fa0235a-99ea-5bed-8307-bcac6a55c546
- DOI
- 10.64898/2026.08.05.741689
